From the magazine
Magazine · Issue 01 · Made in Europe
The latest approvals in Europe
Between March and September, Europe cleared 41 new medicines and a new class of AI-driven diagnostics. European companies led just over half, yet the first-of-their-kind treatments still belong mostly to rare diseases and specialist cancers.
Magazine · Issue 01 · Made in Europe
Jascayd
The story behind a key 2026 EU authorisation, told by the Boehringer Ingelheim teams who spent more than twenty-five years on it.